273 related articles for article (PubMed ID: 8558439)
21. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
Mustafa SB; Howard KM; Olson MS
Hepatology; 1996 Jun; 23(6):1622-30. PubMed ID: 8675186
[TBL] [Abstract][Full Text] [Related]
23. Transferrin induces nitric oxide synthase mRNA in rat cultured aortic smooth muscle cells.
Takenaka K; Suzuki S; Sakai N; Kassell NF; Yamada H
Biochem Biophys Res Commun; 1995 Aug; 213(2):608-15. PubMed ID: 7544123
[TBL] [Abstract][Full Text] [Related]
24. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
Lee DH; Singh JP; Lodge D
Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141
[TBL] [Abstract][Full Text] [Related]
25. Involvement of endogenous nitric oxide in the regulation of K+ channel activity in cultured human proximal tubule cells.
Nakamura K; Habano W; Kojo T; Komagiri Y; Kubota T; Kubokawa M
J Physiol Sci; 2006 Dec; 56(6):407-13. PubMed ID: 17062169
[TBL] [Abstract][Full Text] [Related]
26. The L-arginine/NO pathway in the early phases of platelet stimulation by collagen.
Leoncini G; Bruzzese D; Signorello MG
Biochem Pharmacol; 2005 Jan; 69(2):289-96. PubMed ID: 15627481
[TBL] [Abstract][Full Text] [Related]
27. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production.
Jaroszewski JJ; Bogacki M; Skarzynski DJ
Reproduction; 2003 Mar; 125(3):389-95. PubMed ID: 12611602
[TBL] [Abstract][Full Text] [Related]
28. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.
Radomski MW; Jenkins DC; Holmes L; Moncada S
Cancer Res; 1991 Nov; 51(22):6073-8. PubMed ID: 1718593
[TBL] [Abstract][Full Text] [Related]
29. [Changes in the activity of platelet L-arginine/nitric oxide pathway in hypercholesterolemia patients].
Kou W; Yin S; Nie D; Ma L; Xie S; Li Z; Feng J; Xu L
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):132-4. PubMed ID: 11877063
[TBL] [Abstract][Full Text] [Related]
30. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets.
Tannous M; Rabini RA; Vignini A; Moretti N; Fumelli P; Zielinski B; Mazzanti L; Mutus B
Diabetologia; 1999 May; 42(5):539-44. PubMed ID: 10333045
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production.
Mariano F; Bussolati B; Migliori M; Russo S; Triolo G; Camussi G
Shock; 2003 Apr; 19(4):339-44. PubMed ID: 12688545
[TBL] [Abstract][Full Text] [Related]
32. Studies on the importance of the proposed release of nitric oxide from platelets.
Mollace V; Salvemini D; Vane J
Thromb Res; 1991 Dec; 64(5):533-42. PubMed ID: 1725563
[TBL] [Abstract][Full Text] [Related]
33. L-arginine transport and nitric oxide synthesis in human endothelial progenitor cells.
Díaz-Pérez F; Radojkovic C; Aguilera V; Veas C; González M; Lamperti L; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2012 Nov; 60(5):439-49. PubMed ID: 23143655
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis.
Van Voorhis BJ; Dunn MS; Snyder GD; Weiner CP
Endocrinology; 1994 Nov; 135(5):1799-806. PubMed ID: 7525252
[TBL] [Abstract][Full Text] [Related]
35. Ca(2+)-dependent and Ca(2+)-independent NO-synthesizing activities of human primordial placenta.
Kukor Z; Tóth M
Acta Physiol Hung; 1994; 82(4):313-9. PubMed ID: 7540347
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress, l-arginine-nitric oxide and arginase pathways in platelets from adolescents with anorexia nervosa.
Rodrigues Pereira N; Bandeira Moss M; Assumpção CR; Cardoso CB; Mann GE; Brunini TM; Mendes-Ribeiro AC
Blood Cells Mol Dis; 2010 Mar; 44(3):164-8. PubMed ID: 20071203
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
38. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis.
Steil AA; Garcia Rodriguez MC; Alonso A; Crespo MS; Bosca L
Br J Pharmacol; 1995 Feb; 114(4):895-901. PubMed ID: 7539698
[TBL] [Abstract][Full Text] [Related]
40. Amino acids differentially inhibit the L-[3H]arginine transport and nitric oxide synthase in rat brain synaptosomes.
Lopes MC; Cardoso SA; Schousboe A; Carvalho AP
Neurosci Lett; 1994 Nov; 181(1-2):1-4. PubMed ID: 7534888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
